Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Celltrion Inc (068270 KS)
Watchlist
721
Analysis
Health Care
•
South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Quantitative Analysis
•
10 Dec 2025 07:05
KRX Short Interest Weekly (Dec 5th): LCB, Alteogen, Hyundai Motor, Samsung F&M Insurance, HanmiPharm
We analyzed KRX short interest report for the past week and highlighted short interest changes in LCB, Alteogen, Hyundai Motor, Samsung F&M...
Ke Yan, CFA, FRM
Follow
354 Views
Share
bearish
•
Quantitative Analysis
•
08 Dec 2025 07:05
KRX Foreign Holding Weekly (Dec 5th): SK Hynix, Samsung Electronics, Hyundai Motor, NAVER
We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in SK Hynix, Samsung Electronics, Hyundai Motor,...
Ke Yan, CFA, FRM
Follow
342 Views
Share
bullish
•
Musinsa
•
06 Dec 2025 01:26
2026 ("Year of the Horse") Major IPOs Pipeline in Korea
This is our 11th "Annual Edition of the Major Korean IPOs Pipeline Preview" at Smartkarma. This insight features 40 of the biggest potential IPOs...
Douglas Kim
Follow
1.7k Views
Share
bearish
•
Quantitative Analysis
•
03 Dec 2025 07:00
KRX Short Interest Weekly (Nov 28th): Hanwha Ocean, SK Hynix, Kakaopay, NAVER
We analyzed KRX short interest report for the past week and highlighted short interest changes in Hanwha Ocean, SK Hynix, kakaopay, NAVER, HD...
Ke Yan, CFA, FRM
Follow
309 Views
Share
bearish
•
Quantitative Analysis
•
01 Dec 2025 07:05
KRX Foreign Holding Weekly (Nov 28th): SAMSUNG BIOLOGICS, Samsung Electronics, NAVER
We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in SAMSUNG BIOLOGICS, Samsung Electronics, NAVER, HD...
Ke Yan, CFA, FRM
Follow
391 Views
Share
First
Previous
39
40
41
42
43
44
45
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x